Advertisement
U.S. markets closed
  • S&P 500

    4,975.51
    -30.06 (-0.60%)
     
  • Dow 30

    38,563.80
    -64.19 (-0.17%)
     
  • Nasdaq

    15,630.78
    -144.87 (-0.92%)
     
  • Russell 2000

    2,004.14
    -28.60 (-1.41%)
     
  • Crude Oil

    78.27
    -0.92 (-1.16%)
     
  • Gold

    2,035.50
    -4.30 (-0.21%)
     
  • Silver

    23.03
    -0.10 (-0.44%)
     
  • EUR/USD

    1.0812
    +0.0029 (+0.27%)
     
  • 10-Yr Bond

    4.2750
    -0.0200 (-0.47%)
     
  • GBP/USD

    1.2622
    +0.0027 (+0.22%)
     
  • USD/JPY

    149.9550
    -0.1450 (-0.10%)
     
  • Bitcoin USD

    52,461.76
    +484.08 (+0.93%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,719.21
    -9.29 (-0.12%)
     
  • Nikkei 225

    38,363.61
    -106.77 (-0.28%)
     

Aesthetic Medical International Holdings Group First Quarter 2023 Earnings: EPS: CN¥0.012 (vs CN¥0.15 loss in 1Q 2022)

Aesthetic Medical International Holdings Group (NASDAQ:AIH) First Quarter 2023 Results

Key Financial Results

  • Revenue: CN¥148.9m (down 7.4% from 1Q 2022).

  • Net income: CN¥481.0k (up from CN¥3.23m loss in 1Q 2022).

  • Profit margin: 0.3% (up from net loss in 1Q 2022).

  • EPS: CN¥0.012 (up from CN¥0.15 loss in 1Q 2022).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aesthetic Medical International Holdings Group's share price is broadly unchanged from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Aesthetic Medical International Holdings Group (at least 2 which don't sit too well with us), and understanding these should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

Advertisement